🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluated the bioequivalence and safety of the test formulation ...
Status
Completed
Location
General Hospital of Shenyang Military Region
Start Date
2017-06-20
Trial ID
NCT07558967
The main objective of this trial is to select a formulation principle (tabl...
Status
Terminated
Location
Quotient Sciences
Start Date
2020-02-25
Trial ID
NCT04232839
This single dose study was designed in accordance with EMA (the European Me...
Status
Unknown
Location
Altasciences Company Inc.
Start Date
2019-10-31
Trial ID
NCT04138888
The clinical protocol of the clinical testing of this device: 1. Objective...
Status
Completed
Location
Wuhou District Hospital
Start Date
2014-12
Trial ID
NCT02345109
Treatments Being Tested
This single dose study was designed in accordance with EMA (the European Me...
Status
Completed
Location
Altasciences Company Inc.
Start Date
2019-07-11
Trial ID
NCT04012307
Treatments Being Tested
A double-blind, randomized, 2-period, placebo-controlled, single-center, cr...
Status
Completed
Location
Research Site
Start Date
2017-10-30
Trial ID
NCT03313336
Treatments Being Tested
To study the pharmacokinetic profiles of decitabine and tetrahydrouridine (...
Status
Completed
Location
Worldwide Clinical Trial
Start Date
2019-04-03
Trial ID
NCT03828084
Treatments Being Tested
This Study will investigate the bioavailability in fasting subjects of 1 ca...
Status
Completed
Location
Innolab
Start Date
2021-01-23
Trial ID
NCT04723238
Cefixime is an orally active third generation cephalosporin indicated for t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-01-11
Trial ID
NCT03329547
Treatments Being Tested
This study is being performed to determine the bioavailability, or extent o...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-05
Trial ID
NCT01138826
Treatments Being Tested